Deyrup Cynthia L, Southern Kristal J, Cornett Julie A, Shultz Craig E, Cera Deborah A
Office of Public Health Science, USDA FSIS, 1400 Independence Ave SW, Washington, DC 20250, USA.
J Am Vet Med Assoc. 2012 Jul 15;241(2):249-53. doi: 10.2460/javma.241.2.249.
To determine whether cull dairy cows with signs of certain clinical conditions, termed suspect, are more likely than healthy-appearing cull dairy cows to have violative concentrations of flunixin meglumine in their tissues at slaughter.
Cross-sectional study.
961 cull dairy cows.
Suspect cull dairy cows were selected from 21 beef slaughter establishments with a high production volume of dairy cows, and kidney and liver tissues were collected for screening. Kidney tissues were screened for antibiotics and sulfonamides with the fast antimicrobial screening test (FAST). Liver tissues were screened for flunixin meglumine with an ELISA, and quantitative analysis of ELISA-positive samples was performed with high-performance liquid chromatography. During the same time period, liver tissues from 251 healthy-appearing cull dairy cows were collected for the Food Safety and Inspection Service National Residue Program Scheduled Sampling Plan, but were screened only for flunixin meglumine.
Of 710 suspect cull dairy cows, 50 (7.04%) had liver tissue flunixin concentrations higher than the flunixin tolerance concentration (0.125 ppm). Thirty-one of 168 (18.45%) FAST-positive and 19 of 542 (3.51%) FAST-negative suspect cull dairy cows had violative tissue flunixin concentrations. Two of the 251 (0.80%) healthy-appearing cull dairy cows had violative tissue flunixin concentrations.
Suspect cull dairy cows, especially those that were also FAST positive, had a significantly higher incidence of violative tissue flunixin concentrations than healthy-appearing cull dairy cows at slaughter. Targeted sampling plans for flunixin meglumine in suspect dairy cows can help to support more efficient use of resources and further safeguard the nation's food supply.
确定患有某些临床症状(称为疑似症状)的淘汰奶牛,在屠宰时其组织中氟尼辛葡甲胺浓度超过规定水平的可能性是否高于外观健康的淘汰奶牛。
横断面研究。
961头淘汰奶牛。
从21家奶牛屠宰量高的肉牛屠宰场选取疑似淘汰奶牛,并采集肾脏和肝脏组织进行筛查。用快速抗菌筛选试验(FAST)对肾脏组织进行抗生素和磺胺类药物筛查。用酶联免疫吸附测定法(ELISA)对肝脏组织进行氟尼辛葡甲胺筛查,并用高效液相色谱法对ELISA阳性样本进行定量分析。在同一时期,为食品安全与检验局国家残留计划定期抽样计划采集了251头外观健康的淘汰奶牛的肝脏组织,但仅对氟尼辛葡甲胺进行了筛查。
在710头疑似淘汰奶牛中,50头(7.04%)肝脏组织中氟尼辛浓度高于氟尼辛耐受浓度(0.125 ppm)。168头FAST阳性的疑似淘汰奶牛中有31头(18.45%)以及542头FAST阴性的疑似淘汰奶牛中有19头(3.51%)组织中氟尼辛浓度超标。251头外观健康的淘汰奶牛中有2头(0.80%)组织中氟尼辛浓度超标。
疑似淘汰奶牛,尤其是那些FAST检测也呈阳性的奶牛,在屠宰时组织中氟尼辛浓度超标的发生率显著高于外观健康的淘汰奶牛。针对疑似奶牛的氟尼辛葡甲胺靶向抽样计划有助于更有效地利用资源,并进一步保障国家的食品供应。